Pelvic Inflammatory Disease in COVID-19 Era

Launched by UNIVERSITÀ DEGLI STUDI DI FERRARA · Dec 9, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how the COVID-19 pandemic has affected women with Pelvic Inflammatory Disease (PID). Researchers want to compare the characteristics and experiences of women diagnosed with PID before the lockdown and during the pandemic to see if there are any changes in how often PID occurs and how patients are affected. The study is focused on women aged 65 to 74 who have been diagnosed with PID, while those who are pregnant or have cancer cannot participate.

If you qualify for this study, you can expect to share your health information related to PID and how it may have changed during the pandemic. This research aims to help understand the overall impact of COVID-19 on women's health and could inform better care for patients in the future. The study is currently recruiting participants, so there is an opportunity to contribute to important findings in this area.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pelvic Inflammatory disease
• Exclusion Criteria:
• • Pregnancy Oncologic disease